-
psnet.ahrq.gov/issue/development-and-evaluation-integrated-electronic-prescribing-and-drug-management-system
March 10, 2011 - Study
The development and evaluation of an integrated electronic prescribing and drug management system for primary care.
Citation Text:
Tamblyn R, Huang A, Kawasumi Y, et al. The development and evaluation of an integrated electronic prescribing and drug management system for primary …
-
psnet.ahrq.gov/issue/characteristics-medication-errors-and-adverse-drug-events-hospitals-participating-california
July 13, 2010 - Study
Characteristics of medication errors and adverse drug events in hospitals participating in the California Pediatric Patient Safety Initiative.
Citation Text:
Takata GS, Taketomo CK, Waite S, et al. Characteristics of medication errors and adverse drug events in hospitals particip…
-
psnet.ahrq.gov/issue/impact-drug-shortage-medication-errors-and-clinical-outcomes-pediatric-intensive-care-unit
November 16, 2022 - Study
Impact of a drug shortage on medication errors and clinical outcomes in the pediatric intensive care unit.
Citation Text:
Hughes KM, Goswami ES, Morris JL. Impact of a Drug Shortage on Medication Errors and Clinical Outcomes in the Pediatric Intensive Care Unit. J Pediatr Pharmacol…
-
psnet.ahrq.gov/issue/medication-rounds-tool-promote-medication-safety-children-medical-complexity
February 12, 2020 - Commentary
Medication rounds: a tool to promote medication safety for children with medical complexity.
Citation Text:
Rojas CR, Moore A, Coffin A, et al. Medication rounds: a tool to promote medication safety for children with medical complexity. Jt Comm J Qual Patient Saf. 2023;49(4):2…
-
psnet.ahrq.gov/issue/drug-related-problems-and-pharmacist-interventions-geriatric-unit-employing-electronic
June 26, 2024 - Study
Drug related problems and pharmacist interventions in a geriatric unit employing electronic prescribing.
Citation Text:
Raimbault-Chupin M, Spiesser-Robelet L, Guir V, et al. Drug related problems and pharmacist interventions in a geriatric unit employing electronic prescribing. I…
-
psnet.ahrq.gov/issue/visual-acuity-literacy-and-unintentional-misuse-nonprescription-medications
November 26, 2014 - Study
Visual acuity, literacy, and unintentional misuse of nonprescription medications.
Citation Text:
Mullen RJ, Curtis LM, O'Conor R, et al. Visual acuity, literacy, and unintentional misuse of nonprescription medications. Am J Health-Syst Pharm. 2018;75(9):e213-e220. doi:10.2146/ajhp1…
-
psnet.ahrq.gov/issue/state-medical-board-regulation-compounding-physician-offices
July 13, 2022 - Study
State medical board regulation of compounding in physician offices.
Citation Text:
Reynolds KA, Hellquist K, Ibrahim SA, et al. State medical board regulation of compounding in physician offices. Arch Dermatol Res. 2022;314(4):363-367. doi:10.1007/s00403-021-02237-8.
Copy Citatio…
-
psnet.ahrq.gov/issue/risks-and-medication-errors-analysis-evaluate-impact-chemotherapy-compounding-workflow
January 27, 2019 - Study
Risks and medication errors analysis to evaluate the impact of a chemotherapy compounding workflow management system on cancer patients' safety.
Citation Text:
Marzal-Alfaro MB, Rodriguez-Gonzalez CG, Escudero-Vilaplana V, et al. Risks and medication errors analysis to evaluate the…
-
psnet.ahrq.gov/issue/effectiveness-pharmacist-nurse-intervention-resolving-medication-discrepancies-patients
December 03, 2014 - Study
Effectiveness of a pharmacist–nurse intervention on resolving medication discrepancies for patients transitioning from hospital to home health care.
Citation Text:
Setter SM, Corbett CF, Neumiller JJ, et al. Effectiveness of a pharmacist-nurse intervention on resolving medication…
-
psnet.ahrq.gov/issue/additional-cost-perioperative-medication-errors
July 24, 2024 - Study
The additional cost of perioperative medication errors
Citation Text:
Langlieb ME, Sharma P, Hocevar M, et al. The additional cost of perioperative medication errors. J Patient Saf. 2023;19(6):375-378. doi:10.1097/pts.0000000000001136.
Copy Citation
Format:
DOI Google…
-
psnet.ahrq.gov/issue/drug-manufacturers-delayed-disclosure-serious-and-unexpected-adverse-events-us-food-and-drug
July 10, 2017 - Study
Drug manufacturers' delayed disclosure of serious and unexpected adverse events to the US Food and Drug Administration.
Citation Text:
Ma P, Marinovic I, Karaca-Mandic P. Drug Manufacturers' Delayed Disclosure of Serious and Unexpected Adverse Events to the US Food and Drug Adminis…
-
psnet.ahrq.gov/issue/drug-related-morbidity-and-mortality-and-economic-impact-pharmaceutical-care
December 23, 2008 - Study
Drug-related morbidity and mortality and the economic impact of pharmaceutical care.
Citation Text:
Johnson JA, Bootman JL. Drug-related morbidity and mortality and the economic impact of pharmaceutical care. Am J Health Syst Pharm. 1997;54(5):554-8.
Copy Citation
Format:
…
-
psnet.ahrq.gov/issue/development-proactive-process-harmonize-policy-infusion-pump-library-and-electronic-health
October 19, 2022 - Study
Development of a proactive process to harmonize policy, infusion pump library, and electronic health record entries for continuous infusions at an academic medical center.
Citation Text:
Christensen SM, Andrews SR, Fox ER. Development of a proactive process to harmonize policy, inf…
-
psnet.ahrq.gov/issue/do-emergency-physicians-attribute-drug-related-emergency-department-visits-medication-related
April 22, 2011 - Study
Do emergency physicians attribute drug-related emergency department visits to medication-related problems?
Citation Text:
Hohl CM, Zed PJ, Brubacher JR, et al. Do emergency physicians attribute drug-related emergency department visits to medication-related problems? Ann Emerg Med…
-
psnet.ahrq.gov/issue/h-pepss-instrument-measure-health-professionals-perceptions-patient-safety-competence-entry
February 14, 2015 - Study
The H-PEPSS: an instrument to measure health professionals' perceptions of patient safety competence at entry into practice.
Citation Text:
Ginsburg LR, Castel E, Tregunno D, et al. The H-PEPSS: an instrument to measure health professionals' perceptions of patient safety competen…
-
psnet.ahrq.gov/issue/not-another-safety-culture-survey-using-canadian-patient-safety-climate-survey-can-pscs
February 14, 2015 - Study
'Not another safety culture survey': using the Canadian patient safety climate survey (Can-PSCS) to measure provider perceptions of PSC across health settings.
Citation Text:
Ginsburg LR, Tregunno D, Norton PG, et al. 'Not another safety culture survey': using the Canadian patien…
-
psnet.ahrq.gov/issue/optimizing-use-dose-error-reduction-software-intravenous-infusion-pumps
August 02, 2015 - Study
Optimizing the use of dose error reduction software on intravenous infusion pumps.
Citation Text:
Hughes K, Cole M, Tims D, et al. Optimizing the use of dose error reduction software on intravenous infusion pumps. Hosp Pediatr. 2024;14(6):448-454. doi:10.1542/hpeds.2023-007385.
C…
-
psnet.ahrq.gov/issue/tallman-lettering-strategy-differentiation-look-alike-sound-alike-drug-names-role-familiarity
May 27, 2020 - Study
Tallman lettering as a strategy for differentiation in look-alike, sound-alike drug names: the role of familiarity in differentiating drug doppelgangers.
Citation Text:
DeHenau C, Becker MW, Bello NM, et al. Tallman lettering as a strategy for differentiation in look-alike, sound-a…
-
psnet.ahrq.gov/issue/oncology-nurses-beliefs-and-attitudes-towards-double-check-chemotherapy-medications-cross
September 07, 2016 - Study
Oncology nurses' beliefs and attitudes towards the double-check of chemotherapy medications: a cross-sectional survey study.
Citation Text:
Schwappach DLB, Taxis K, Pfeiffer Y. Oncology nurses' beliefs and attitudes towards the double-check of chemotherapy medications: a cross-sect…
-
psnet.ahrq.gov/issue/fda-drug-safety-communication-fda-warns-about-prescribing-and-dispensing-errors-resulting
August 05, 2020 - Press Release/Announcement
FDA Drug Safety Communication: FDA warns about prescribing and dispensing errors resulting from brand name confusion with antidepressant Brintellix (vortioxetine) and antiplatelet Brilinta (ticagrelor).
Citation Text:
FDA Drug Safety Communication: FDA warns ab…